• Latest Posts

FDA approves Beyfortus ahead of 2023-24 RSV season

Hope for Alzheimer’s patients after Lilly drug results

Westlake launches $450M fund for LA biotechs

Lilly boosts obesity portfolio with Versanis Bio acquisition

Life saved: AI discovers existing drug works for rare disease

TME Pharma provides positive glioblastoma trial results


BioGeneration Ventures closes BGV Fund V at €150M 

Calliditas reveals ‘encouraging results’ from head and neck cancer trial 

Partnership to progress neurodegenerative disorder treatments

Gene therapy company EG 427 raises €18M

New venture capital company Biovance Capital Partners launches

ADC Therapeutics pauses clinical trial following patient deaths